Colin MD Broom - Aug 2, 2022 Form 4 Insider Report for Nabriva Therapeutics plc (NBRV)

Role: Director
Signature: /s/ J. Christopher Naftzger, by power of attorney
Stock symbol: NBRV
Transactions as of: Aug 2, 2022
Transactions value $: -$1,015
Form type: 4
Date filed: 8/4/2022, 06:22 PM
Previous filing: Aug 4, 2021

Transactions Table

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Ownership	Footnotes
transaction	NBRV	Ordinary Shares	Sale	-$1.02K	-5.34K	-12.75%	$0.19^*	36.5K	Aug 2, 2022	Direct	F1

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id	Content
F1	The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $0.1902 to $0.1911, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the U.S. Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.

Content

The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $0.1902 to $0.1911, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the U.S. Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.